Assignee
ADORX THERAPEUTICS LTD
GB·0 granted patents·6 pending applications·0 citations·filing 2018–2023
Top patents by PatentIndex Score
6 records- 0163US2025243194A1Antagonist of adenosine receptorsADORX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0258US2025340565A1Cd73 inhibitor compoundsADORX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0353US2023293517A1Antagonist compoundsADORX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0450US2024083904A1Antagonists of the adenosine a2a receptorADORX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0547US2023203041A1Antagonists of the adenosine a2a receptorADORX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0644US2020339548A1Pyrimidine derivatives and their use for the treatment of cancerADORX THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ADORX THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →